CEN Biotech Inc., the Canadian subsidiary of Creat

CEN Biotech Inc., the Canadian subsidiary of Creative Edge, received its required municipal clearance, but hasn’t been given the green light from Health Canada just yet. Across Canada, seven producers have received a license to begin production, according to the health department’s website. Still, Chaaban says he hopes to have the $12 million facility up and running by late May. The company is putting the final touches on its indoor facility, and soon will go through final government inspections.